<DOC>
	<DOCNO>NCT02022709</DOCNO>
	<brief_summary>The purpose study evaluate efficiency SSRIs（Selective Serotonin Reuptake Inhibitor） , ERP（Exposure Response Prevention） combination two therapy OCD ( Obsessive-Compulsive Disorder ) patient , time , find biological psychological predictor treatment response Chinese population .</brief_summary>
	<brief_title>Efficacy Exposure Response Prevention ( ERP ) SSRIs Chinese OCD Patients</brief_title>
	<detailed_description>Although Selective Serotonin Reuptake Inhibitors ( SSRIs ) Cognitive Behavior Therapy ( CBT ) include Exposure Response Prevention ( ERP ) two kind first line treatment OCD ( Obsessive-Compulsive Disorder ) accord APA（American Psychological Association）guideline . Both treatment effective , research do find responsive one treatment . The aim research evaluate efficiency SSRIs , ERP combination two therapy OCD patient , time , find biological psychological predictor treatment response Chinese population . This randomized , single-blind , cross-over design study.Approximately 60 patient randomized SSRIs ERP group . Neuropsychological assessment fMRI ( Functional Magnetic Resonance Imaging） perform baseline , treatment end study . The research two period . In first period ( week 8 ) , patient monotherapy . In second period ( week 8 ) , rate improvement base YBOCS ( Yale-Brown Obsessive Compulsive Scale ) score assess . The patient consider responsive treatment reduction YBOCS score ≥ 35 % score baseline.If patient responsive treatment receive first 8 week , continue follow previous treatment strategy.If , patient combination SSRIs ERP treatment another 8 week . The follow-up period last 6 months.The result study improve knowledge efficacy two first line treatment .Also , help u find predictor outcome two different kind treatments.Strategy clinical treatment OCD individualized future .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Having diagnose primary OCD define Diagnostic Statistical Manual Mental Disorders ( DSMIV ) criterion ; Cleaning check primary OCD symptom YaleBrown ObsessiveCompulsive Scale ( YBOCS ) score ≥ 16 Never receive adequate treatment stop receive treatment least 8 week Having education degree high school Accepting participate study Having significant medical illness would interfere conduct study Clinically significant abnormal laboratory find Having comorbid psychiatric condition accord criterion set forth DSMIV ( administer MiniInternational Neuropsychiatric Interview ( MINI ) ) The current OCD symptom severe patient finish evaluation receive ERP Being currently risk suicide Being pregnant intention pregnant end study A history inadequate response adequate SSRIs CBT treatment Subjects unable undergo MRI</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cognitive Behavior Therapy</keyword>
	<keyword>Exposure Response/Ritual Prevention</keyword>
	<keyword>Selective Serotonin Reuptake Inhibitors</keyword>
	<keyword>Psychotherapy</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Citalopram</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Fluvoxamine</keyword>
	<keyword>fMRI</keyword>
	<keyword>Stop Signal Task</keyword>
</DOC>